| Valley Care Home Health, Inc. | |
| 353 E Angeleno Ave, Ste J, Burbank, California 91502 | |
| (818) 556-3611 | |
| Name | Valley Care Home Health, Inc. |
|---|---|
| Location | 353 E Angeleno Ave, Ste J, Burbank, California |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 59411 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 90001, 90002, 90005, 90006, 90007, 90011, 90016, 90017, 90018, 90019, 90022, 90023, 90027, 90028, 90029, 90031, 90032, 90033, 90034, 90037, 90038, 90041, 90044, 90057, 90061, 90063, 90065, 90201, 90221, 90222, 90250, 90255, 90262, 90280, 90301, 90405, 90503, 90605, 90640, 90650, 90660, 90710, 90723, 90731, 90746, 90806, 90814, 90815, 91042, 91201, 91202, 91203, 91204, 91205, 91206, 91214, 91303, 91304, 91331, 91335, 91342, 91344, 91352, 91401, 91402, 91403, 91405, 91406, 91501, 91502, 91504, 91605, 91607, 91732, 91744, 91755, 91766, 91768, 93551 |
| Quality Rating: |
News Archive
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.
A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.
The Cooperative of American Physicians, Inc. (CAP) announced that beginning today it will automatically provide enhanced group disability insurance and add term life insurance as benefits of CAP membership. These products will be made available through the organization's wholly owned subsidiary, CAP Physicians Insurance Agency, Inc.
MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 96.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.3 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 88.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 15 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.
A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.
The Cooperative of American Physicians, Inc. (CAP) announced that beginning today it will automatically provide enhanced group disability insurance and add term life insurance as benefits of CAP membership. These products will be made available through the organization's wholly owned subsidiary, CAP Physicians Insurance Agency, Inc.
MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 100 | 79.6 |
| How often patients got better at getting in and out of bed | 100 | 81.1 |
| How often patients got better at bathing | 89.9 | 82.3 |
| How often patients’ breathing improved | 100 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 94.3 | 75 |
| How often home health patients had to be admitted to the hospital | 10.3 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 9.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 100 | 94 |
News Archive
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.
A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.
The Cooperative of American Physicians, Inc. (CAP) announced that beginning today it will automatically provide enhanced group disability insurance and add term life insurance as benefits of CAP membership. These products will be made available through the organization's wholly owned subsidiary, CAP Physicians Insurance Agency, Inc.
MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.
A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.
The Cooperative of American Physicians, Inc. (CAP) announced that beginning today it will automatically provide enhanced group disability insurance and add term life insurance as benefits of CAP membership. These products will be made available through the organization's wholly owned subsidiary, CAP Physicians Insurance Agency, Inc.
MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.
› Verified 7 days ago
The patient survey data of Valley Care Home Health, Inc. is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 81 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 82 | 78 |
News Archive
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.
A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.
The Cooperative of American Physicians, Inc. (CAP) announced that beginning today it will automatically provide enhanced group disability insurance and add term life insurance as benefits of CAP membership. These products will be made available through the organization's wholly owned subsidiary, CAP Physicians Insurance Agency, Inc.
MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.
› Verified 7 days ago
Med-life Home Health, Inc Location: 1701 W Burbank Blvd, Suite 203, Burbank, California 91506 Ratings: Phone: (818) 569-0209 | |
Revive Home Health Care, Inc Location: 1918 W Magnolia Blvd, Suite 200, Burbank, California 91506 Ratings: Phone: (909) 949-6566 | |
Zion Nursing Services, Inc Location: 224 East Olive Ave, Suite 214, Burbank, California 91502 Ratings: Phone: (818) 736-5358 | |
Lakewood Home Health & Palliative Care Inc Location: 539 N Glenoaks Blvd, Suite 301f, Burbank, California 91502 Ratings: Phone: (626) 414-3358 | |
Oc Home Health Care, Inc Location: 2001 W Magnolia Blvd, Burbank, California 91502 Ratings: Phone: (747) 229-9200 | |
Allstar Home Healthcare, Inc Location: 2001 West Magnolia Blvd, Suite A1, Burbank, California 91506 Ratings: Phone: (818) 556-5270 |